Zymeworks, Inc. (ZYME)
26.41
-1.20
(-4.35%)
USD |
NASDAQ |
May 07, 12:02
Zymeworks SG&A Expense (TTM) : 61.51M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Royalty Pharma Plc | 462.50M |
| Johnson & Johnson | 24.60B |
| Krystal Biotech, Inc. | 114.19M |
| Alnylam Pharmaceuticals, Inc. | 1.293B |
| Catalyst Pharmaceuticals, Inc. | 171.18M |